Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00053287
Status:
COMPLETED
Last Update Posted:
2010-06-10
First Post:
2003-01-27
Brief Title:
FludarabineCarboplatinTopotecan wThalidomide for RelapsedRefractory AML CML and MDS
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Organization Data
Organization:
Case Comprehensive Cancer Center
Class:
OTHER
Study ID:
CWRU1902
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Case Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Brenda Cooper MD
Old Organization:
Ireland Cancer Center at University Hospitals Case Medical Center Case Comprehensive Cancer Center
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |